The Patent Finder

Terms ending in 2037

Translate Bio, Inc.

Every in-force patent on Translate Bio, Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,266,843Multimeric Coding Nucleic Acid and Uses Thereof
In force
 · High confidence
Translate Bio, Inc.In forceHigh confidence
US 10,428,349Multimeric Coding Nucleic Acid and Uses Thereof
In force
 · High confidence
Translate Bio, Inc.In forceHigh confidence
US 11,124,804Multimeric Coding Nucleic Acid and Uses Thereof
In force
 · High confidence
Translate Bio, Inc.In forceHigh confidence
US 12,533,402Mrna Therapy for Argininosuccinate Synthetase Deficiency
In force
 · Medium confidence
Translate Bio, Inc.In forceMedium confidence
US 11,998,601Messenger RNA Therapy for Treatment of Articular Disease
In force
 · High confidence
Translate Bio, Inc.In forceHigh confidence
US 10,940,207Ice-Based Lipid Nanoparticle Formulation for Delivery of Mrna
In force
 · High confidence
Translate Bio, Inc.In forceHigh confidence
US 11,013,812Ice-Based Lipid Nanoparticle Formulation for Delivery of Mrna
In force
 · High confidence
Translate Bio, Inc.In forceHigh confidence
US 11,400,109Subcutaneous Delivery of Messenger RNA
In force
 · High confidence
Translate Bio, Inc.In forceHigh confidence
US 12,758,508Process of Preparing mRNA-Loaded Lipid Nanoparticles
In force
 · Medium confidence
Translate Bio, Inc.In forceMedium confidence
US 12,778,976Subcutaneous Delivery of Messenger RNA
In force
 · High confidence
Translate Bio, Inc.In forceHigh confidence
10 of 10 patents shown. Soonest term end first, then patent number.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited